Provided by Tiger Fintech (Singapore) Pte. Ltd.

ReShape Lifesciences, Inc.

0.3946
+0.01142.97%
Post-market: 0.3925-0.0021-0.53%19:59 EDT
Volume:10.03M
Turnover:4.08M
Market Cap:4.45M
PE:-0.03
High:0.4360
Open:0.3943
Low:0.3700
Close:0.3832
Loading ...
May 19, 2021

Major Issues Report

8-K - Current report
May 18, 2021

Major Issues Report

8-K - Current report
May 18, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 18, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 17, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 13, 2021

Major Issues Report

8-K - Current report
May 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2021

Major Issues Report

8-K - Current report
May 04, 2021

Major Issues Report

8-K - Current report
May 04, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Apr 09, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 15, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 12, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals